Updated

More than 90 lawsuits have been filed against pharmaceutical companies manufacturing GLP-1 drugs (used for diabetes and weight loss), with plaintiffs alleging the medications caused rare eye conditions resulting in vision loss. The legal action represents growing concerns about previously unreported or inadequately disclosed adverse effects of the increasingly popular weight-loss and diabetes medications.